AGT and hypertensive disorder: We recently tested this hypothesis that AVE-0657 attenuates Ang II-induced hypertension in mice primarily by inhibiting NHE3 and Na+ reabsorption in the proximal tubules (Figure 6; Li et al., 2019b; Zhuo et al., 2021).